Free Trial

Quantbot Technologies LP Raises Stock Holdings in The Pennant Group, Inc. (NASDAQ:PNTG)

The Pennant Group logo with Medical background
Remove Ads

Quantbot Technologies LP raised its stake in The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 100.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 31,263 shares of the company's stock after acquiring an additional 15,632 shares during the quarter. Quantbot Technologies LP owned approximately 0.09% of The Pennant Group worth $829,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Quarry LP increased its position in The Pennant Group by 371.6% during the 3rd quarter. Quarry LP now owns 1,014 shares of the company's stock worth $36,000 after purchasing an additional 799 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. increased its holdings in shares of The Pennant Group by 460.2% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,311 shares of the company's stock worth $118,000 after buying an additional 2,720 shares in the last quarter. Intech Investment Management LLC acquired a new position in shares of The Pennant Group during the third quarter worth $232,000. Arizona State Retirement System lifted its stake in shares of The Pennant Group by 13.0% in the 4th quarter. Arizona State Retirement System now owns 9,773 shares of the company's stock valued at $259,000 after acquiring an additional 1,121 shares during the last quarter. Finally, HighTower Advisors LLC acquired a new stake in shares of The Pennant Group during the 3rd quarter valued at $282,000. 85.88% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Truist Financial lowered their target price on The Pennant Group from $32.00 to $28.00 and set a "hold" rating for the company in a report on Friday, March 7th. Wells Fargo & Company began coverage on shares of The Pennant Group in a research note on Thursday, December 19th. They set an "equal weight" rating and a $33.00 target price on the stock. Finally, Stephens restated an "overweight" rating and issued a $38.00 target price on shares of The Pennant Group in a report on Tuesday, March 11th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $34.80.

Remove Ads

View Our Latest Report on PNTG

The Pennant Group Trading Down 3.2 %

Shares of NASDAQ:PNTG traded down $0.81 on Friday, hitting $24.61. The company had a trading volume of 216,643 shares, compared to its average volume of 220,090. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.58. The Pennant Group, Inc. has a 1 year low of $19.37 and a 1 year high of $37.13. The firm has a market capitalization of $847.32 million, a price-to-earnings ratio of 36.19, a P/E/G ratio of 2.24 and a beta of 2.06. The firm's 50-day simple moving average is $25.40 and its two-hundred day simple moving average is $29.21.

The Pennant Group Company Profile

(Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Further Reading

Institutional Ownership by Quarter for The Pennant Group (NASDAQ:PNTG)

Should You Invest $1,000 in The Pennant Group Right Now?

Before you consider The Pennant Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.

While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads